A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
Edema due to obstruction of lymph vessels or disorders of the lymph nodes.
Radiographic study of the lymphatic system following injection of dye or contrast medium.
Tubular vessels that are involved in the transport of LYMPH and LYMPHOCYTES.
Radionuclide imaging of the LYMPHATIC SYSTEM.
Mycoses are a group of diseases caused by fungal pathogens that can infect various tissues and organs, potentially leading to localized or systemic symptoms, depending on the immune status of the host.
Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.
The superior part of the upper extremity between the SHOULDER and the ELBOW.

Lymphangiosarcomas in cats: a retrospective study of 12 cases. (1/15)

Clinical, macroscopic, and histologic features of 12 lymphangiosarcomas in cats are described. Nine tumors were located in the subcutaneous tissue at the caudoventral abdominal wall (eight cats) or in the neck (one cat). The remaining three cats had lymphangiosarcomas around the cranial mesenteric artery (two cats) or precardial in the mediastinum (one cat). Macroscopically, the tumors were noncircumscribed, white, edematous, and intermixed with fat tissue. Histologic features varied from cleft-forming and cavernous growth to papilliform and solid patterns. Follow-up data were available for seven cats with subcutaneous lymphangiosarcomas. All these cats died or were euthanatized within 6 months after surgery because of poor wound healing, local recurrence, or distant metastases. The cats with abdominal or thoracic masses were either euthanatized at surgery or within 6 months after the first surgery because of recurrent chylothorax, chyloperitoneum, or distant metastases.  (+info)

The risk of angiosarcoma following primary breast cancer. (2/15)

Lymphangiosarcoma of the upper extremity is a rare and aggressive tumour reported to occur following post-mastectomy lymphoedema (Stewart-Treves syndrome). Haemangiosarcoma, a related rare tumour, has occasionally been reported to occur in the breast following irradiation. We conducted a case-control study using the University of Southern California-Cancer Surveillance Program, the population-based cancer registry for Los Angeles County, to evaluate the relationship between invasive female breast cancer and subsequent upper extremity or chest lymphangiosarcoma and haemangiosarcoma together referred to as angiosarcoma. Cases were females diagnosed between 1972 and 1995 with angiosarcoma of the upper extremity (n = 20) or chest (n = 48) who were 25 years of age or older and residing in Los Angeles County when diagnosed. Other sarcomas at the same anatomic sites were also studied. Controls were females diagnosed with cancers other than sarcoma during the same time period (n = 266,444). Cases and controls were then compared with respect to history of a prior invasive epithelial breast cancer. A history of breast cancer increased the risk of upper extremity angiosarcoma by more than 59-fold (odds ratio [OR] = 59.3, 95% confidence interval [95% CI] = 21.9-152.8). A strong increase in risk after breast cancer was also observed for angiosarcoma of the chest and breast (OR = 11.6, 95% CI = 4.3-26.1) and for other sarcomas of the chest and breast (OR = 3.3, 95% CI = 1.1-1.7).  (+info)

Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases. (3/15)

Primary angiosarcoma of the spleen is a rare neoplasm that has not been well characterized. We describe the clinical, morphologic, and immunophenotypic findings of 28 cases of primary splenic angiosarcoma, including one case that shares features of lymphangioma/lymphangiosarcoma. The patients included 16 men and 12 women, aged 29 to 85 years, with a mean of 59 years and median of 63 years. The majority of patients (75%) complained of abdominal pain, and 25% presented with splenic rupture. The most common physical finding was splenomegaly (71%). Seventeen of 21 patients were reported to have anemia. Macroscopic examination showed splenomegaly in 85% cases. Sectioning revealed discrete lesions in 88% of cases, ranging from well-circumscribed firm nodules to poorly delineated foci of necrosis and hemorrhage associated with cystic spaces. Microscopically, the tumors were heterogenous; however, all cases demonstrated at least a focal vasoformative component lined by atypical endothelial cells. Solid sarcomatous, papillary, and epithelioid growth patterns were observed. The solid sarcomatous component resembled fibrosarcoma in two cases and malignant fibroushistiocytoma in one case. Hemorrhage, necrosis, hemosiderin, extramedullary hematopoiesis, and intracytoplasmic hyaline globules were frequently identified. A panel of immunohistochemical studies revealed that the majority of tumors were immunoreactive for at least two markers of vascular differentiation (CD34, FVIIIRAg, VEGFR3, and CD31) and at least one marker of histiocytic differentiation (CD68 and/or lysozyme). Metastases developed in 100% of patients during the course of their disease. Twenty-six patients died of disease despite aggressive therapy, whereas only two patients are alive at last follow-up, one with disease at 8 years and the other without disease at 10 years. In conclusion, primary splenic angiosarcoma is an extremely aggressive neoplasm that is almost universally fatal. The majority of splenic angiosarcomas coexpress histiocytic and endothelial markers by immunohistochemical analysis, which suggest that some tumors may originate from splenic lining cells.  (+info)

Metastatic lymphangiosarcoma in a horse. (4/15)

A lymphangiosarcoma with metastases was found in a horse that presented with respiratory distress and edema in the ventral thorax and abdomen. The necropsy revealed diffuse edema in the subcutaneous connective tissue. Mediastinal, mesenteric, iliac, and renal lymph nodes were enlarged and white with soft, yellowish necrotic areas. Histologic examination revealed numerous channels and disorganized vessels lined by large polyhedral, polymorphic cells. Tumor metastases were observed in the spleen, lungs, and kidneys. Immunohistochemical evaluation of the tumor cells demonstrated positive staining for factor VIII, vimentin, and keratin. Laminin was scarce, and collagen IV staining was negative, consistent with a discontinuous or absent basement membrane.  (+info)

Platelet-derived growth factor receptor-beta in Gorham's disease. (5/15)

BACKGROUND: A 17-year-old male presented with pain in his lower-left chest. He had no significant medical history and was previously in good health. He had a fractured ninth left anterior rib and the tenth, eleventh and twelfth ribs were absent, which was thought to be a congenital anomaly. Several months later, he presented again with back pain, an enlarging mass in the lower-left chest wall, erosion of the lateral pedicles of the lower thoracic vertebrae and pleural effusion. INVESTIGATIONS: Physical examination, chest X-ray, MRI of the spine, incisional biopsy, serial CT imaging of the hemithorax, immunohistochemistry, flow cytometry, and enzyme-linked immunosorbent assays. DIAGNOSIS: Gorham's lymphangiomatosis with expression of platelet-derived growth factor receptor-beta and elevated circulating platelet-derived growth factor-BB. MANAGEMENT: Spine stabilization, thalidomide, celecoxib, interferon-alpha2b, pamidronate, zoledronate, thoracotomy, pleurectomy, talc pleurodesis, and imatinib mesylate.  (+info)

Lymphangiosarcoma in the nictitating membrane of a horse. (6/15)

A 15-year-old Haflinger gelding presented with a mass in the left nictitating membrane. Two biopsies and the excised nictitating membrane were taken at different time points as a result of reoccurrence of the mass and submitted for histopathologic evaluation. The horse was euthanized as a result of poor prognosis following the reoccurrence of the mass after surgical removal. Histologically, the mass consisted of dilated, thin-walled vascular clefts and channels, lined by flattened to cuboidal endothelial cells with moderate cellular pleomorphism. There was up to 1 mitotic figure per high power field. The channels were empty or contained few erythrocytes. In the collagen-rich stroma, few lymphocytes, focal follicular lymphoid aggregations, and marked lymphangiectasia were observed. Immunohistochemically, the neoplastic cells stained positive for vimentin and partially positive for factor VIII-related antigen. Ultrastructural analysis revealed discontinuous endothelial lining vascular channels that partially lacked a basal membrane. Based on the histopathologic, immunohistochemical, and ultrastructural features lymphangiosarcoma was diagnosed.  (+info)

A Stewart-Treves syndrome of the lower limb. (7/15)

We report a case of a Stewart-Treves syndrome of the lower limb. The tumor is best described in the upper limb following breast cancer treatment but a small number of cases have arisen in lymphedema of the lower limb. Electrochemotherapy could be useful in the palliative treatment of this lymphangiosarcoma.  (+info)

Elevated coagulation factor VIII plasma activity in a patient with lymphangiosarcoma. (8/15)

A 72-year-old woman was referred to our hospital for palliative care. Fifteen years earlier, she had undergone total hysterectomy and radiotherapy for cervical cancer. One year before her referral, she visited a hospital due to a gait disturbance and was diagnosed with lymphangiosarcoma. The level of coagulation factor VIII plasma activity was >201% (normal range: 62-145%) and the immunohistochemical results were positive for factor VIII-related antigen in a tumor specimen. To the best of our knowledge, this is the first report of high coagulation factor VIII plasma activity in a patient with lymphangiosarcoma.  (+info)

Lymphangiosarcoma is a rare and aggressive type of soft tissue cancer that originates from the lymphatic vessels. It primarily affects the skin, particularly in patients who have had long-standing lymphedema (chronic swelling of a body part due to lymph fluid accumulation). The condition is also known as Stewart-Treves syndrome when it occurs in the upper limb of postmastectomy lymphedematous extremities.

Lymphangiosarcoma is characterized by the proliferation of malignant cells within the walls of the lymphatic vessels, leading to the formation of tumors that can ulcerate and bleed. The cancer can metastasize (spread) to other parts of the body, such as the lungs and liver, making it a serious and life-threatening condition.

The diagnosis of lymphangiosarcoma typically involves a combination of clinical examination, imaging studies, and biopsy. Treatment usually includes surgical resection of the tumor, followed by radiation therapy and chemotherapy to reduce the risk of recurrence and metastasis. However, due to its rarity and aggressiveness, lymphangiosarcoma has a poor prognosis, with a low survival rate.

Hemangiosarcoma is a type of cancer that arises from the cells that line the blood vessels (endothelial cells). It most commonly affects middle-aged to older dogs, but it can also occur in cats and other animals, as well as rarely in humans.

This cancer can develop in various parts of the body, including the skin, heart, spleen, liver, and lungs. Hemangiosarcomas of the skin tend to be more benign and have a better prognosis than those that arise internally.

Hemangiosarcomas are highly invasive and often metastasize (spread) to other organs, making them difficult to treat. The exact cause of hemangiosarcoma is not known, but exposure to certain chemicals, radiation, and viruses may increase the risk of developing this cancer. Treatment options typically include surgery, chemotherapy, and/or radiation therapy, depending on the location and stage of the tumor.

Lymphedema is a chronic condition characterized by swelling in one or more parts of the body, usually an arm or leg, due to the accumulation of lymph fluid. This occurs when the lymphatic system is unable to properly drain the fluid, often as a result of damage or removal of lymph nodes, or because of a genetic abnormality that affects lymphatic vessel development.

The swelling can range from mild to severe and may cause discomfort, tightness, or a feeling of heaviness in the affected limb. In some cases, lymphedema can also lead to skin changes, recurrent infections, and reduced mobility. The condition is currently not curable but can be managed effectively with various treatments such as compression garments, manual lymphatic drainage, exercise, and skincare routines.

Lymphography is not a commonly used term in current medical practice. However, historically, it referred to a radiographic imaging technique that involved the injection of a contrast material into the lymphatic system to visualize the lymph nodes and lymph vessels. This procedure was used primarily for diagnostic purposes, particularly in the evaluation of cancerous conditions like lymphoma or melanoma.

The process typically involved injecting a radiopaque substance into the interstitial tissue, which would then be taken up by the lymphatic vessels and transported to the regional lymph nodes. X-ray imaging was used to track the progression of the contrast material, creating detailed images of the lymphatic system.

Due to advancements in medical imaging technology, lymphography has largely been replaced by other non-invasive imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. These modern methods provide high-resolution images of the body's internal structures without requiring invasive procedures or the use of contrast materials.

Lymphatic vessels are thin-walled, valved structures that collect and transport lymph, a fluid derived from the interstitial fluid surrounding the cells, throughout the lymphatic system. They play a crucial role in immune function and maintaining fluid balance in the body. The primary function of lymphatic vessels is to return excess interstitial fluid, proteins, waste products, and immune cells to the bloodstream via the subclavian veins near the heart.

There are two types of lymphatic vessels:

1. Lymphatic capillaries: These are the smallest lymphatic vessels, found in most body tissues except for the central nervous system (CNS). They have blind ends and are highly permeable to allow the entry of interstitial fluid, proteins, and other large molecules.
2. Larger lymphatic vessels: These include precollecting vessels, collecting vessels, and lymphatic trunks. Precollecting vessels have valves that prevent backflow of lymph and merge to form larger collecting vessels. Collecting vessels contain smooth muscle in their walls, which helps to propel the lymph forward. They also have valves at regular intervals to ensure unidirectional flow towards the heart. Lymphatic trunks are large vessels that collect lymph from various regions of the body and eventually drain into the two main lymphatic ducts: the thoracic duct and the right lymphatic duct.

Overall, lymphatic vessels play a vital role in maintaining fluid balance, immune surveillance, and waste removal in the human body.

Lymphoscintigraphy is a medical imaging technique that uses radioactive tracers to examine the lymphatic system, specifically the lymph nodes and vessels. In this procedure, a small amount of radioactive material is injected into the area of interest, usually an extremity or the site of a surgical incision. The tracer then travels through the lymphatic channels and accumulates in the regional lymph nodes. A specialized camera called a gamma camera detects the radiation emitted by the tracer and creates images that reveal the function and anatomy of the lymphatic system.

Lymphoscintigraphy is often used to diagnose and assess conditions affecting the lymphatic system, such as lymphedema, cancer metastasis to lymph nodes, or unusual lymphatic flow patterns. It can help identify sentinel lymph nodes (the first node(s) to receive drainage from a tumor) in patients with melanoma and breast cancer, which is crucial for surgical planning and staging purposes.

In summary, lymphoscintigraphy is a non-invasive imaging technique that utilizes radioactive tracers to visualize the lymphatic system's structure and function, providing valuable information for diagnostic and therapeutic decision-making in various clinical scenarios.

Mycoses are a group of diseases caused by fungal infections. These infections can affect various parts of the body, including the skin, nails, hair, lungs, and internal organs. The severity of mycoses can range from superficial, mild infections to systemic, life-threatening conditions, depending on the type of fungus and the immune status of the infected individual. Some common types of mycoses include candidiasis, dermatophytosis, histoplasmosis, coccidioidomycosis, and aspergillosis. Treatment typically involves antifungal medications, which can be topical or systemic, depending on the location and severity of the infection.

Elephantiasis, filarial is a medical condition characterized by the severe swelling of limbs or other parts of the body due to the blockage of lymphatic vessels by parasitic worms. It is caused by infection with threadlike nematode filarial worms, such as Wuchereria bancrofti and Brugia timori. These worms are transmitted to humans through mosquito bites.

The blockage of lymphatic vessels leads to the accumulation of lymph fluid in the affected area, causing progressive swelling, thickening, and hardening of the skin and underlying tissues. In advanced cases, the skin may become rough, nodular, and fissured, resembling the hide of an elephant, hence the name "elephantiasis."

The condition is usually chronic and can cause significant disability and social stigma. While there is no cure for filarial elephantiasis, various treatments are available to alleviate symptoms, prevent transmission, and halt the progression of the disease. These include antibiotics to kill the worms, surgery to remove the lymphatic obstruction, and various supportive measures to manage the swelling and prevent secondary infections.

In medical terms, the arm refers to the upper limb of the human body, extending from the shoulder to the wrist. It is composed of three major bones: the humerus in the upper arm, and the radius and ulna in the lower arm. The arm contains several joints, including the shoulder joint, elbow joint, and wrist joint, which allow for a wide range of motion. The arm also contains muscles, blood vessels, nerves, and other soft tissues that are essential for normal function.

... is a rare cancer which occurs in long-standing cases of primary or secondary lymphedema. It involves either ... Lymphangiosarcoma may present as a purple discoloration or a tender skin nodule in the extremity, typically on the anterior ... The pathogenesis of lymphangiosarcoma has not been resolved, however several vague mechanisms have been proposed. Stewart and ... Verdier E, Carvalho P, Young P, Musette P, Courville P, Joly P. Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx)] ...
Lymphangiosarcoma usually occurs many years following a mastectomy, usually between 5 and 15 years. Cutaneous angiosarcoma can ... Lymphangiosarcoma arising from cancer-related lymphedema has become much less common with better surgical techniques, radiation ... Prognosis is generally poor, and the 5 year survival rate of patients with lymphangiosarcoma is less than 5%. In the 1960s, the ... Stewart-Treves syndrome refers to a lymphangiosarcoma, a rare disorder marked by the presence of an angiosarcoma (a malignant ...
... -associated lymphangiosarcoma is called Stewart-Treves syndrome. Lymphangiosarcoma most frequently occurs in cases of ... lymphedema may lead to a form of cancer called lymphangiosarcoma, although the mechanism of carcinogenesis is not understood. ...
"Systemic Chlamydial infection associated with generalized lymphedema and lymphangiosarcoma". Lymphology. 6 (3): 113-21. PMID ...
"Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica." Cancer, 1948 "Occupational ...
Two cases of lymphangiosarcoma arising from lymphangioma circumscriptum have been reported; however, in both of the patients, ...
However, glomangiosarcoma (8710/3) and lymphangiosarcoma (9170/3) are distinct conditions (in humans). Hemangiosarcoma is quite ...
A rare complication is the appearance of lymphangiosarcoma or angiosarcoma in patients with persistent lymphedema. Some ...
Lymphangiosarcoma is a malignant soft tissue tumour, whereas lymphangioma is a benign tumour occurring frequently in ...
Postinflammatory lymphedema Postmastectomy lymphangiosarcoma (Stewart-Treves syndrome) Purpura fulminans (purpura gangrenosa) ...
... lymphangiosarcoma MeSH C04.557.450.795.530 - mixed tumor, mesodermal MeSH C04.557.450.795.550 - myosarcoma MeSH C04.557.450.795 ... lymphangiosarcoma MeSH C04.557.386.345 - histiocytosis, malignant MeSH C04.557.386.355 - hodgkin disease MeSH C04.557.386.390 ...
NOS M9170/3 Lymphangiosarcoma Lymphangioendothelial sarcoma Lymphangioendothelioma, malignant M9171/0 Capillary lymphangioma ...
... lymphangiosarcoma - lymphatic fluid - lymphatic mapping - lymphatic system - lymphatic vessel - lymphedema - lymphoblast - ...
Lymphangiosarcoma is a rare cancer which occurs in long-standing cases of primary or secondary lymphedema. It involves either ... Lymphangiosarcoma may present as a purple discoloration or a tender skin nodule in the extremity, typically on the anterior ... The pathogenesis of lymphangiosarcoma has not been resolved, however several vague mechanisms have been proposed. Stewart and ... Verdier E, Carvalho P, Young P, Musette P, Courville P, Joly P. Lymphangiosarcoma treated with liposomal doxorubicin (Caelyx)] ...
Lymphangiosarcoma. Lymphangiosarcoma is a rare malignancy that reportedly develops in 0.1% of patients with lymphedema of the ...
What is a lymphangiosarcoma?. Some lymphatic tumors are benign (lymphangioma) and some are malignant (lymphangiosarcoma). Both ...
Start your 7 day free trial. Trusted and used in more than 2,300 hospitals, large clinics, and medical schools to improve clinical decision-making.. Start Trial Subscriber Sign In ...
Lymphangiosarcoma * Lymphoma * Lymphopenia * Malignant Fibrous Histiocytoma (MFH) * Malignant Glomus Tumor * Malignant Granular ...
Grade 4: Progression to malignancy (e.g., lymphangiosarcoma); amputation indicated; disabling lymphedema. ...
Lymphangiosarcoma - arises from lymphatic tissue. *Neurofibrosarcoma - or nerve sheath tumor arises from nerve cells ...
Autophagy inhibition prevents lymphatic malformation progression to lymphangiosarcoma by decreasing osteopontin and Stat3 ... of osteopontin and its downstream Stat3 signaling contributes to lymphatic malformation progression to lymphangiosarcoma. ...
... chance of developing a cancer of the lymphatic vessels known as lymphangiosarcoma. The cancer begins as a reddish or purplish ... leading to frequent infections and even a malignant tumor of lymph vessels known as lymphangiosarcoma. ...
Long-term, or chronic, lymphedema can cause lymphangiosarcoma (also called Stewart-Treves syndrome). This is a rare type of ...
... lymphangiosarcoma or hemangiopericytoma.. 2. A rare malignant tumor of vascular origin, formed by proliferation of endothelial ...
Tomita K, Yokogawa A, Oda Y, Terahata S. Lymphangiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome): ...
Lymphangiosarcoma (1963-2016). Lymphedema (1963-2016). Postoperative Complications (1963-2016). Public MeSH Note:. 2017. ...
SYSTEMIC CHLAMYDIAL INFECTION ASSOCIATED WITH GENERALIZED LYMPHEDEMA AND LYMPHANGIOSARCOMA. M Elvin-Lewis, MH Witte, Ch Witte, ...
... system are lined with cells very similar to those found in blood vessels and give rise to what is termed lymphangiosarcoma. ...
Lymphangiosarcoma: a rare complication of chronic lymphedema, sometimes referred to as Stewart-Treves Syndrome (Komoroswski AL ...
infection, lymphedema, lymphangiosarcoma.Axillary vein thrombosis- early postop sudden swellinglymphatic fibrosis- swelling ...
Lymphangiosarcoma (morphologic abnormality). Code System Preferred Concept Name. Lymphangiosarcoma (morphologic abnormality). ...
A knowledge graph of biological entities such as genes, gene functions, diseases, phenotypes and chemicals. Embeddings are generated with Walking RDF and OWL method ...
Lymphangiosarcoma *A rare cutaneous malignancy that can develop in patients with long-standing chronic lymphedema ...
Lymphangiosarcoma Afterload (proportional to peripheral resistance) Tetrology of fallot - pulmonary stenosis - RVH - overiding ...
Topics pertaining to the urinary tract (kidneys, ureter, bladder, urethra), adrenal glands, prostate penis, scrotal content (testes, epididymis and associated structures), but excluding those specific to obstetric curriculum and gynecology curriculum.. ...
Lymphangioma/lymphangiosarcoma. Metastatic neoplasm. Extramural masses. Primary neoplasm of adjacent organs (benign and ...
Lymphangiosarcoma, a malignant cancer tumor that develops in lymph vessels, is a very rare complication of chronic lymphedema. ...
Lymphangiosarcoma - cancer of the lymphatic system. Clinical signs of lymphedema can include:. *Localized swelling of the skin ...
Rarely, long-standing lymphedema leads to lymphangiosarcoma (Stewart-Treves syndrome), usually in postmastectomy patients and ...
... lymphangiosarcoma, lymphangioendotheliosarcoma, rhabdomyosarcoma, myosarcoma, colon carcinoma, pancreatic cancer, breast cancer ... lymphangiosarcoma, lymphangioendotheliosarcoma, rhabdomyosarcoma, myosarcoma, colon carcinoma, pancreatic cancer, breast cancer ...
Lymphangiosarcoma may also develop after other forms of lymphedema as a consequence of the weaker immune system which is linked ... Lymphangiosarcoma can develop years after breast removal for breast cancer treatment. It requires immediate treatment with ... A very rare complication of long-lasting lymphedema is the development of lymphangiosarcoma, an aggressive type of soft tissue ...
In rare cases, Stewart-Treves syndrome and lymphangio-sarcoma may present.. A study involving stage I and II breast cancer ...
  • Lymphangiosarcoma is a rare cancer which occurs in long-standing cases of primary or secondary lymphedema. (wikipedia.org)
  • Because of this change in clinical practice lymphedema is now a rarity following breast cancer treatment-and post-mastectomy lymphangiosarcoma is now vanishingly rare. (wikipedia.org)
  • Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. (wikipedia.org)
  • Therefore, considering these elements, in more recent publications, lymphangiosarcoma has been classified as angiosarcoma associated with lymphedema. (lymphaticsurgery.it)
  • A significant reduction has been reported in the incidence of lymphangiosarcoma in patients undergoing rigorous medical-physical therapies and microsurgery to treat lymphedema. (lymphaticsurgery.it)
  • Lymphangiosarcoma is a rare type of cancer that occurs with long-term chronic cases of lymphedema (swollen lymph nodes). (withoutaribbon.org)
  • Massive lymphedema (swollen lymph nodes) of the arms, as well as some immunodeficiency and autoimmune diseases, are the causes of the development of lymphangiosarcoma. (withoutaribbon.org)
  • 1. Complex karyotype in a case of cutaneous lymphangiosarcoma associated with chronic lymphedema of the lower limb. (nih.gov)
  • 2. Lymphangiosarcoma of the pubic region: a rare complication arising in congenital non-hereditary lymphedema. (nih.gov)
  • 3. Lymphangiosarcoma arising in congenital lymphedema. (nih.gov)
  • 5. Lymphangiosarcoma in chronic lymphedema that followed dissection of the groin in surgical management of a malignant melanoma. (nih.gov)
  • 15. Malignant degeneration to lymphangiosarcoma of a chronic lymphedema in the lower left extremity. (nih.gov)
  • Lymphangiosarcoma at the base of a chronic lymphedema following breast ablation]. (nih.gov)
  • Lymphangiosarcoma in late-onset hereditary lymphedema: case report and nosological implications. (nih.gov)
  • Untreated severe cases of lymphedema can result to lymphangiosarcoma. (therapygarments.com)
  • In rare cases, lymphedema can lead to a form of cancer called lymphangiosarcoma, although the mechanism of carcinogenesis is not understood. (siddhaspirituality.com)
  • Lymphedema-associated lymphangiosarcoma is called Stewart-Treves syndrome. (siddhaspirituality.com)
  • Lymphangiosarcoma most frequently occurs in cases of long-standing lymphedema. (siddhaspirituality.com)
  • Lymphedema can escalate into lymphangiosarcoma, an incurable malignancy. (superduperior.com)
  • Untreated, chronic lymphedema can also lead to fatal lymphangiosarcoma. (bluemagazinez.com)
  • Stewart FW, Treves N. Lymphangiosarcoma in post-mastectomy lymphedema: a report of six cases in elephantiasis chirurgica. (ijcto.org)
  • Untreated edema and lymphedema can lead to serious complications such as cellulitis, skin changes, or even lymphangiosarcoma. (fabriza.co.uk)
  • Lymphangiosarcoma is a rare malignant soft tissue tumor originating from lymphatic endothelium cells. (lymphaticsurgery.it)
  • The most successful treatment for lymphangiosarcoma is amputation of the affected limb if possible. (wikipedia.org)
  • Lymphangiosarcoma is rare cancer, meaning it is not as well-known as other forms of cancer. (withoutaribbon.org)
  • If you suffer from rare cancer such as Lymphangiosarcoma, we can help and support you through your journey thanks to the generous donations we receive. (withoutaribbon.org)
  • Lymphangiosarcoma may present as a purple discoloration or a tender skin nodule in the extremity, typically on the anterior surface. (wikipedia.org)